Scientific Advisory Board

Greg Landes, Ph.D.

VP of R&D at Takeda

VP of Biotherapeutics at Lexicon Pharma

VP of R&D at Abgenix

VP, Genzyme

PhD, University of Kansas

"At the scientific advisory board meeting, the Biosion management team revealed a deep understanding of creating antibody drug design goals for each program as a critical means to achieve superior antibody drugs. Furthermore, they demonstrated their strong technical capabilities in B-cell immortalization and drug screening to identify and recover rare antibodies that meet or exceed their drug design goals." — Dr. Greg Landes

 

Michael Karin, Ph.D.

Distinguished Professor of Pharmacology, UCSD

Member, National Academy Sciences

PhD, University of California, Los Angeles

"Biosion has the most impressive system for generation high quality therapeutic antibodies." — Dr. Michael Karin

 

 

 

 

 

 

Lei Zheng, MD, Ph.D.

Oncologist, Johns Hopkins University

PhD, University of Texas Health Science Center

MD, Peking Union Medical University

"Biosion has a strong innovative mind, a hardworking force, and a comprehensive pipeline." — Dr. Lei Zheng

 

 

 

 

 

 

Bing Su, Ph.D.

Chair, Department of Immunology and Microbiology,

Shanghai Jiao Tong University School of Medicine

PhD, Yale University

"My observation is that Biosion has a highly talented leadership team and innovative systems for producing high quality and broad spectrum therapeutic antibodies with a vision of becoming a global player." — Dr. Bing Su